Targeted Drug Delivery System for Cardiovascular Diseases Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 May 2024 | Viewed by 158
Special Issue Editors
Interests: nanotechnology; lipid formulations; drug delivery; drug targeting; cellular models; animal models; oxidative stress; antioxidants
Special Issues, Collections and Topics in MDPI journals
Interests: antihypertensive; antiatherogenic; cardioprotective; diuretic; lipid-lowering; vasodilator
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVD) are the main causes of illness and death globally. Hypertension is the leading risk factor that exacerbates the occurrence, seriousness, and advancement of different types of cardiovascular diseases, which include arteriosclerosis and thrombosis. The association between hypertension, arteriosclerosis and other cardiovascular disorders increases the risk of undesirable outcomes in different patient groups. There are various options available for treating CVD, including synthetic drugs and herbal medicines. However, numerous compounds and extracts have not yet undergone thorough scientific investigation in terms of drug delivery, drug dosage forms, and pharmaceutical formulations. As a result, there is a requirement for systematic endeavors to establish the effectiveness and safety of these formulations.
In this Special Issue, we invite researchers to submit studies on drug dosage form design, targeted drug delivery, pharmacokinetics, and biopharmaceutics focusing on advancements in the treatment of cardiovascular diseases. We gladly accept both original research and review articles. Potential submission topics may include, but are not restricted to:
- Dosage forms and drug delivery systems;
- Characterization of biopharmaceutical formulations;
- Standardization and evaluation of herbal drug formulations;
- Quality control in drug development;
- Excipient–drug interactions;
- Pharmacokinetics studies in drug discovery.
Dr. Graciela Pavon-Djavid
Dr. Arquimedes Gasparotto Junior
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- biopharmaceutical
- quality control
- cardioprotection
- hypertension
- drug development
- arteriosclerosis
- thrombosis
